Compare FDP & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDP | WGS |
|---|---|---|
| Founded | 1886 | 2017 |
| Country | Cayman Islands | United States |
| Employees | N/A | 1300 |
| Industry | Farming/Seeds/Milling | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1999 | N/A |
| Metric | FDP | WGS |
|---|---|---|
| Price | $41.83 | $58.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $130.71 |
| AVG Volume (30 Days) | 264.5K | ★ 661.5K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.88 | N/A |
| Revenue | ★ $4,322,300,000.00 | N/A |
| Revenue This Year | N/A | $29.98 |
| Revenue Next Year | $3.14 | $25.92 |
| P/E Ratio | ★ $22.75 | $1,251.58 |
| Revenue Growth | ★ 0.98 | N/A |
| 52 Week Low | $30.92 | $55.17 |
| 52 Week High | $43.58 | $170.87 |
| Indicator | FDP | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 52.44 | 33.00 |
| Support Level | $39.86 | $55.18 |
| Resistance Level | $43.30 | $95.75 |
| Average True Range (ATR) | 1.32 | 4.26 |
| MACD | 0.06 | 0.25 |
| Stochastic Oscillator | 65.10 | 16.20 |
Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.